The new, now-defeated bill eliminated the PBM reform measures included in a larger spending bill that the president-elect and ...

The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Women are more than twice as likely to develop post-traumatic stress disorder than men, and a new study demonstrates for the ...

The boxed warning follows a safety warning the FDA issued in September about the risk of liver injury from the use of Veozah ...

Menopausal gay, lesbian and bisexual women are more likely to report recent sexual activity with less vaginal symptoms than ...

A new bill in Congress would require pass-through prices in both Medicare, and Medicaid and require transparency of PBM ...

A pooled analysis of two prior trials suggests patients with a variety of cardiac index scores saw improvement when Winrevair ...

The combination of Spinraza and Zolgensma could improve clinical outcomes in infants with spinal muscular atrophy without ...

If approved, clesrovimab would be the first and only FDA approved single dose immunization for infants approved in time for ...

In past trials, ketamine intravenous treatment has shown promise, with 64% of depression patients in trials experiencing ...

Spending reached $4.86 trillion in 2023, a 7.5% increase from 2022 The growth in spending on hospital care was the highest since 1990.